APA

Cefalo G., Massimino M., Ruggiero A., Barone G., Ridola V., Spreafico F., Potepan P., Abate M. E., Mascarin M., Garrè M. L., Perilongo G., Madon E., Colosimo C. & Riccardi R. (20150331). Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial. : Neuro-oncology.

Chicago

Cefalo Graziella, Massimino Maura, Ruggiero Antonio, Barone Giuseppe, Ridola Vita, Spreafico Filippo, Potepan Paolo, Abate Massimo E, Mascarin Maurizio, Garrè Maria Luisa, Perilongo Giorgio, Madon Enrico, Colosimo Cesare and Riccardi Riccardo. 20150331. Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial. : Neuro-oncology.

Harvard

Cefalo G., Massimino M., Ruggiero A., Barone G., Ridola V., Spreafico F., Potepan P., Abate M. E., Mascarin M., Garrè M. L., Perilongo G., Madon E., Colosimo C. and Riccardi R. (20150331). Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial. : Neuro-oncology.

MLA

Cefalo Graziella, Massimino Maura, Ruggiero Antonio, Barone Giuseppe, Ridola Vita, Spreafico Filippo, Potepan Paolo, Abate Massimo E, Mascarin Maurizio, Garrè Maria Luisa, Perilongo Giorgio, Madon Enrico, Colosimo Cesare and Riccardi Riccardo. Temozolomide is an active agent in children with recurrent medulloblastoma/primitive neuroectodermal tumor: an Italian multi-institutional phase II trial. : Neuro-oncology. 20150331.